In Silico ADME–Toxicity Profiling of 3,4-dithia-1-azabicyclo[3.2.0]heptan-7-one: Integrating Drug-Likeness, Pharmacokinetics, and Prediction Confidence. Journal of Medical and Health Sciences (JMHS), v. 5, n. 1, p. 61–80, 14 Sep.2026.